Charles Schwab Investment Management Inc Heron Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,105,803 shares of HRTX stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,105,803
Previous 1,096,385
0.86%
Holding current value
$2.69 Million
Previous $2.18 Million
22.47%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding HRTX
# of Institutions
172Shares Held
114MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$64.9 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$20.7 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$20.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$19.8 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$17 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $289M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...